| Name | Title | Contact Details |
|---|
Formycon ist ein führender und unabhängiger Entwickler von qualitativ hochwertigen biopharmazeutischen Nachfolgeprodukten, sogenannten Biosimilars.
Oragenics is a publicly-traded biopharmaceutical company with a pipeline of unique proprietary technologies.
We Develop first in class therapies for basal cell carcinomas, including those in gorlin syndrome.
With a passion for pioneering breakthrough solutions, we are committed to the advancement of immuno-oncology through the engagement of new and complementary phagocytic pathways that enhance anti-tumor efficacy and selectivity.